Details
Stereochemistry | ACHIRAL |
Molecular Formula | C29H27F3N6O |
Molecular Weight | 532.5606 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
Cc1ccc(cc1C#Cc2nnc3ccccn32)C(=O)Nc4ccc(CN5CCN(C)CC5)c(c4)C(F)(F)F
InChI
InChIKey=SLIVDYMORZGPLW-UHFFFAOYSA-N
InChI=1S/C29H27F3N6O/c1-20-6-7-22(17-21(20)9-11-27-35-34-26-5-3-4-12-38(26)27)28(39)33-24-10-8-23(25(18-24)29(30,31)32)19-37-15-13-36(2)14-16-37/h3-8,10,12,17-18H,13-16,19H2,1-2H3,(H,33,39)
Molecular Formula | C29H27F3N6O |
Molecular Weight | 532.5606 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Jun 26 03:19:43 UTC 2021
by
admin
on
Sat Jun 26 03:19:43 UTC 2021
|
Record UNII |
I8C3R768IZ
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Code | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
FDA ORPHAN DRUG |
585217
Created by
admin on Sat Jun 26 03:19:43 UTC 2021 , Edited by admin on Sat Jun 26 03:19:43 UTC 2021
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
71475839
Created by
admin on Sat Jun 26 03:19:43 UTC 2021 , Edited by admin on Sat Jun 26 03:19:43 UTC 2021
|
PRIMARY | |||
|
I8C3R768IZ
Created by
admin on Sat Jun 26 03:19:43 UTC 2021 , Edited by admin on Sat Jun 26 03:19:43 UTC 2021
|
PRIMARY | |||
|
1416241-23-0
Created by
admin on Sat Jun 26 03:19:43 UTC 2021 , Edited by admin on Sat Jun 26 03:19:43 UTC 2021
|
PRIMARY | |||
|
DB15396
Created by
admin on Sat Jun 26 03:19:43 UTC 2021 , Edited by admin on Sat Jun 26 03:19:43 UTC 2021
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> INHIBITOR |
COMPETITIVE INHIBITOR
IC50
|
||
|
TARGET -> INHIBITOR |
COMPETITIVE INHIBITOR
IC50
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |